BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 16356577)

  • 1. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation on therapeutic alliance with UDCA and glucocorticoids in AIH-PBC overlap syndrome].
    Zhu JY; Shi YQ; Han ZY; Jia G; Li ZS; Huang XF; Wang JH; Wang RA; Zhou XM; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):334-9. PubMed ID: 21645439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
    Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P
    Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
    Arulprakash S; Sasi AD; Bala MR; Pugazhendhi T; Kumar SJ
    J Assoc Physicians India; 2010 Jul; 58():455-6. PubMed ID: 21121216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
    Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
    Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of autoimmune hepatitis in primary biliary cirrhosis.
    Gossard AA; Lindor KD
    Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap syndromes.
    Beuers U; Rust C
    Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.
    Silveira MG; Talwalkar JA; Angulo P; Lindor KD
    Am J Gastroenterol; 2007 Jun; 102(6):1244-50. PubMed ID: 17319931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary biliary cirrhosis.
    Poupon R; Poupon RE
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study.
    Fan X; Zhu Y; Men R; Wen M; Shen Y; Lu C; Yang L
    Can J Gastroenterol Hepatol; 2018; 2018():1965492. PubMed ID: 30155449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.